Biogen Inc.
BIIB
$119.26
$4.093.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.87% | -2.55% | 0.36% | -7.00% | -6.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.87% | -2.55% | 0.36% | -7.00% | -6.20% |
| Cost of Revenue | -5.63% | -3.17% | -15.32% | -24.85% | 8.30% |
| Gross Profit | 5.84% | -2.33% | 5.35% | -0.43% | -10.39% |
| SG&A Expenses | 11.61% | -23.36% | 2.57% | -4.41% | -4.72% |
| Depreciation & Amortization | 18.80% | 113.96% | 64.27% | 55.98% | 38.27% |
| Other Operating Expenses | 5.16% | 37.23% | 9.67% | 14.89% | 54.26% |
| Total Operating Expenses | 0.08% | -13.51% | -8.71% | -14.40% | 1.39% |
| Operating Income | 14.49% | 89.06% | 26.48% | 20.80% | -28.52% |
| Income Before Tax | -0.03% | 419.41% | -1.33% | 6.05% | -51.71% |
| Income Tax Expenses | -41.92% | 185.73% | 0.26% | 40.83% | -21.36% |
| Earnings from Continuing Operations | 7.15% | 668.81% | -1.63% | 1.50% | -54.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -11.11% |
| Net Income | 6.81% | 670.48% | -1.35% | 1.42% | -54.63% |
| EBIT | 14.49% | 89.06% | 26.48% | 20.80% | -28.52% |
| EBITDA | 18.41% | 75.52% | 27.87% | 22.68% | -21.40% |
| EPS Basic | 6.22% | 666.96% | -1.96% | 0.86% | -54.88% |
| Normalized Basic EPS | 36.74% | 57.81% | 14.77% | 6.20% | -40.25% |
| EPS Diluted | 6.30% | 665.60% | -1.72% | 1.12% | -54.89% |
| Normalized Diluted EPS | 37.13% | 57.37% | 15.17% | 6.28% | -40.13% |
| Average Basic Shares Outstanding | 0.55% | 0.62% | 0.62% | 0.55% | 0.56% |
| Average Diluted Shares Outstanding | 0.27% | 0.90% | 0.27% | 0.48% | 0.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |